Legend Biotech Corporation
LEGN
$35.64
-$0.27-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -218.15M | -177.03M | -348.13M | -285.01M | -465.95M |
| Total Depreciation and Amortization | 21.95M | 22.47M | 20.78M | 20.29M | 19.92M |
| Total Amortization of Deferred Charges | 886.00K | 886.00K | 1.13M | 1.32M | 1.07M |
| Total Other Non-Cash Items | 91.70M | 1.69M | 90.83M | 28.15M | 151.85M |
| Change in Net Operating Assets | -159.69M | 7.94M | 77.79M | 92.62M | 54.56M |
| Cash from Operations | -263.31M | -144.03M | -157.60M | -142.63M | -238.54M |
| Capital Expenditure | -9.86M | -14.11M | -16.07M | -19.38M | -22.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -53.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -187.89M | -836.44M | -339.12M | -873.96M | -297.29M |
| Cash from Investing | -197.76M | -850.54M | -355.19M | -893.34M | -319.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.04M | -4.02M | -2.78M | -3.34M | -3.70M |
| Issuance of Common Stock | 9.57M | 9.72M | 9.73M | 7.01M | 796.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.53M | 5.70M | 6.96M | 3.67M | 792.77M |
| Foreign Exchange rate Adjustments | -342.00K | -2.09M | 1.64M | 336.00K | 2.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -455.87M | -990.96M | -504.19M | -1.03B | 237.52M |